Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | FUCA1 | P04066 | 2/20 | 0.37 |
| ▸ | GLB1 | P16278 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CA12 | O43570 | 3/20 | 0.36 |
| ▸ | CA1 | P00915 | 3/20 | 0.36 |
| ▸ | CA2 | P00918 | 3/20 | 0.36 |
| ▸ | CA7 | P43166 | 3/20 | 0.36 |
| ▸ | CA9 | Q16790 | 3/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.36 |
| ▸ | ESR1 | P03372 | 1/20 | 0.36 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.35 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30468187 | 1.00 | TSHR (0.38) | TSHRFUCA1GLB1MEN1LMNA | |
| SCHEMBL3650538 | 1.00 | TSHR (0.38) | TSHRFUCA1GLB1MEN1LMNA | |
| SCHEMBL15144345 | 1.00 | TSHR (0.38) | TSHRFUCA1GLB1MEN1LMNA | |
| SCHEMBL13984986 | 1.00 | TSHR (0.38) | TSHRFUCA1GLB1MEN1LMNA | |
| SCHEMBL2829330 | 0.85 | LMNA (0.43) | TSHRMEN1LMNAKMT2ACYP3A4 | |
| SCHEMBL24418103 | 0.84 | MEN1 (0.40) | TSHRFUCA1GLB1MEN1LMNA | |
| Hydrochloric Acid SCHEMBL2829328 | 0.84 | LMNA (0.42) | TSHRMEN1LMNAKMT2ACYP3A4 | |
| SCHEMBL23084653 | 0.83 | MIF (0.32) | — | |
| SCHEMBL3277593 | 0.82 | SLC7A5 (0.31) | — | |
| SCHEMBL14905976 | 0.81 | CHRM3 (0.36) | TSHRFUCA1LMNAKMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122079832-A | Selective reduction method of ketal (acetal) for preparing darifene epoxy intermediate | — | 2026-05-26 | — | — | CN | claimed |
| CN-113677658-B | Flow synthesis method for producing oseltamivir | 纳尔逊·曼德拉大学 | 2024-12-10 | — | — | CN | claimed |
| EP-3938343-B1 | FLOW SYNTHESIS PROCESS FOR THE PRODUCTION OF OSELTAMIVIR | NELSON MANDELA UNIV (ZA) | 2024-10-09 | — | — | EP | claimed |
| CN-118580147-A | Synthesis process of ethyl shikimate catalyzed by cation exchange resin | 浙江得乐康食品股份有限公司 | 2024-09-03 | — | — | CN | claimed |
| CN-118084963-A | Preparation method of prostaglandin intermediate protected by silicon reagent | 华东理工大学 | 2024-05-28 | — | — | CN | claimed |
| CN-116836075-A | Preparation method of oseltamivir phosphate catalyzed by azide-free palladium-free catalyst | 华东理工大学 | 2023-10-03 | — | — | CN | claimed |
| CN-113677658-A | Flow synthesis method for producing oseltamivir | 纳尔逊·曼德拉大学 | 2021-11-19 | — | — | CN | claimed |
| CN-102816078-A | Preparation method of N-(5-methoxycarbonyl-2-hydroxyphenyl) amino acid ester compounds | CAS GUANGZHOU CHEMISTRY CO LTD | 2012-12-12 | — | — | CN | claimed |
| CN-101538221-A | Preparation method of Oseltamivir phosphate | UNIV EAST CHINA SCIENCE & TECH | 2009-09-23 | — | — | CN | claimed |
| CN-122079832-A | Selective reduction method of ketal (acetal) for preparing darifene epoxy intermediate | — | 2026-05-26 | — | — | CN | disclosed |
| CN-122079832-A | Selective reduction method of ketal (acetal) for preparing darifene epoxy intermediate | — | 2026-05-26 | — | — | CN | disclosed |
| CN-113677658-B | Flow synthesis method for producing oseltamivir | 纳尔逊·曼德拉大学 | 2024-12-10 | — | — | CN | disclosed |
| CN-118580147-A | Synthesis process of ethyl shikimate catalyzed by cation exchange resin | 浙江得乐康食品股份有限公司 | 2024-09-03 | — | — | CN | disclosed |
| CN-118580147-A | Synthesis process of ethyl shikimate catalyzed by cation exchange resin | 浙江得乐康食品股份有限公司 | 2024-09-03 | — | — | CN | disclosed |
| WO-2009079876-A1 | 3-ACYLATED SHIKIMIC ACID OR METHYL (ETHYL) SHIKIMATE | JIANGNAN UNIVERSITY (CN) | 2009-07-02 | — | — | WO | disclosed |
| WO-2009079876-A1 | 3-ACYLATED SHIKIMIC ACID OR METHYL (ETHYL) SHIKIMATE | JIANGNAN UNIVERSITY (CN) | 2009-07-02 | — | — | WO | disclosed |
| CN-101351438-A | Epoxide intermediate in the tamiflu synthesis | ROCHE PALO ALTO LLC (CH) | 2009-01-21 | — | — | CN | disclosed |
| US-7473798-B2 | Derivatives of unsaturated, cyclic organic acids | ROCHE PALO ALTO LLC (US) | 2009-01-06 | — | — | US | disclosed |
| US-20070197807-A1 | Derivatives of unsaturated, cyclic organic acids | GABEL RICHARD A | 2007-08-23 | — | — | US | disclosed |
| WO-2007074091-A2 | EPOXIDE INTERMEDIATE IN THE TAMIFLU SYNTHESIS | F. HOFFMANN-LA ROCHE AG (CH) | 2007-07-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070197807-A1 | Derivatives of unsaturated, cyclic organic acids | ALOX5, VKORC1, ELOVL5 | TSHR 4005/4885FUCA1 3922/4885GLB1 1945/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.